Enterprise Value
1.076B
Cash
321M
Avg Qtr Burn
-13.24M
Short % of Float
18.87%
Insider Ownership
1.09%
Institutional Own.
-
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Bexicaserin (LP352) Details Epilepsy, Lennox-Gastaut syndrome, Dravet syndrome, Developmental and Epileptic Encephalopathy | Phase 3 Initiation | |
LP659 Details Neurological disorder | Phase 1 Data readout |